These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 9035610
1. Platelet inhibitory effect of nitroglycerin in platelet-rich plasma: relevance of glutathione-s-transferases in plasma. Chen LY, Mehta P, Mehta JL. J Investig Med; 1996 Dec; 44(9):561-5. PubMed ID: 9035610 [Abstract] [Full Text] [Related]
4. Bioactivation of nitroglycerin to nitric oxide (NO) and S-nitrosothiols in the rat liver and evaluation of the coexisting hypotensive effect. Sokołowska M, Bednarski M, Kwiecień I, Filipek B, Włodek L. Fundam Clin Pharmacol; 2004 Aug; 18(4):449-56. PubMed ID: 15312151 [Abstract] [Full Text] [Related]
5. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia. Aoki H, Inoue M, Mizobe T, Harada M, Imai H, Kobayashi A. Br J Anaesth; 1997 Oct; 79(4):476-81. PubMed ID: 9389267 [Abstract] [Full Text] [Related]
6. Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases. Chung SJ, Chong S, Seth P, Jung CY, Fung HL. J Pharmacol Exp Ther; 1992 Feb; 260(2):652-9. PubMed ID: 1738115 [Abstract] [Full Text] [Related]
7. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin. Matsumoto T, Takahashi M, Nakae I, Kinoshita M. J Pharmacol Exp Ther; 1995 Dec; 275(3):1247-53. PubMed ID: 8531088 [Abstract] [Full Text] [Related]
8. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL. Biochem Biophys Res Commun; 2000 Dec 20; 279(2):412-9. PubMed ID: 11118301 [Abstract] [Full Text] [Related]
9. Manipulating glutathione-S-transferases may prevent the development of tolerance to nitroglycerin. Wang L, Yang Y, Dwivedi S, Xu Y, Chu ET, Li J, Fitchett K, Boor PJ. Cardiovasc Toxicol; 2006 Dec 20; 6(2):131-44. PubMed ID: 17303920 [Abstract] [Full Text] [Related]
10. Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase. O'Byrne S, Shirodaria C, Millar T, Stevens C, Blake D, Benjamin N. J Pharmacol Exp Ther; 2000 Jan 20; 292(1):326-30. PubMed ID: 10604966 [Abstract] [Full Text] [Related]
11. Comparative platelet inhibitory effects of human neutrophils and lymphocytes. Nicolini FA, Wilson AC, Mehta P, Mehta JL. J Lab Clin Med; 1990 Aug 20; 116(2):147-52. PubMed ID: 2168463 [Abstract] [Full Text] [Related]
12. Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets. Wong K, Li X. Transfus Apher Sci; 2004 Feb 20; 30(1):29-39. PubMed ID: 14746819 [Abstract] [Full Text] [Related]
15. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats. Booth BP, Jacob S, Bauer JA, Fung HL. J Cardiovasc Pharmacol; 1996 Sep 20; 28(3):432-8. PubMed ID: 8877591 [Abstract] [Full Text] [Related]
16. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R. Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591 [Abstract] [Full Text] [Related]
18. Inhibitory effect of staphylokinase on platelet aggregation. Suehiro A, Oura Y, Ueda M, Kakishita E. Thromb Haemost; 1993 Nov 15; 70(5):834-7. PubMed ID: 7510426 [Abstract] [Full Text] [Related]
19. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development. Chung SJ, Fung HL. Biochem Pharmacol; 1993 Jan 07; 45(1):157-63. PubMed ID: 8424809 [Abstract] [Full Text] [Related]